Tc 99m P 748
Latest Information Update: 08 Sep 2006
At a glance
- Originator Bayer Schering Pharma
- Developer Bayer Schering Pharma; Merck & Co
- Class Imaging agents; Radiopharmaceuticals; Technetium compounds
- Mechanism of Action Image enhancers; Platelet glycoprotein GPIIb-IIIa complex anatgonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Pulmonary embolism
Most Recent Events
- 08 Sep 2006 Discontinued - Phase-II for Diagnostic imaging in European Union (unspecified route)
- 08 Sep 2006 Discontinued - Phase-II for Diagnostic imaging in USA (unspecified route)
- 16 Nov 1999 Diatide has been acquired by Schering AG